Literature DB >> 18163002

Tuberculosis.

Khalid F Tabbara1.   

Abstract

PURPOSE OF REVIEW: The purpose of this report is to present an update on the manifestations and management of ocular tuberculosis. RECENT
FINDINGS: Tuberculosis affects one-third of the world's population. The incidence of tuberculosis has increased with the increase in the HIV infected population. Following a resurgence of the disease in the US, the incidence has recently declined. Patients may develop scleritis that can be focal, nodular or diffuse with or without keratitis. Anterior granulomatous uveitis may occur. The posterior segment reveals vitritis, choroiditis, and can mimic serpiginous choroiditis and other entities. Patients who are immunosuppressed or HIV infected may develop active mycobacterial disease in the eye leading to rapid destruction of the ocular structures. The diagnosis of ocular tuberculosis is made by isolation of Mycobacterium tuberculosis on Löwestein-Jensen medium or by PCR. The diagnosis is supported by the clinical findings, imaging techniques including optical coherence tomography, fluorescein angiography, indocyanine green and ultrasonography. Tuberculin skin test helps to confirm the diagnosis.
SUMMARY: Ocular tuberculosis may occur in the absence of pulmonary disease. Patients present with a spectrum of clinical signs. The disease may mimic several clinical entities. Early diagnosis and prompt treatment of ocular tuberculosis may prevent ocular morbidity and blindness.

Entities:  

Mesh:

Year:  2007        PMID: 18163002     DOI: 10.1097/ICU.0b013e3282f06d2e

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  20 in total

1.  Spectral domain optical coherence tomography imaging of tubercular chorioretinitis and intraretinal granuloma. Intraretinal tuberculosis: a case report.

Authors:  Maria P Pirraglia; Paolo Tortorella; Alessandro Abbouda; Fabrizio Toccaceli; Maurizio La Cava
Journal:  Int Ophthalmol       Date:  2015-03-27       Impact factor: 2.031

Review 2.  Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis.

Authors:  Hossein Nazari Khanamiri; Narsing A Rao
Journal:  Surv Ophthalmol       Date:  2013-03-27       Impact factor: 6.048

3.  Scrofuloderma and bilateral anterior staphyloma of eye: an unusual association.

Authors:  Asim K Kandar; Rajesh Sinha; Namrata Sharma; K Mathew James; Shveta J Bali; Jeewan S Titiyal
Journal:  Middle East Afr J Ophthalmol       Date:  2011-01

Review 4.  Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology.

Authors:  Frances E Lennon; Patrick A Singleton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

5.  Tubercular serpiginous-like choroiditis.

Authors:  Marta Esteves Guedes; José Nuno Galveia; Ana Catarina Almeida; João Marques Costa
Journal:  BMJ Case Rep       Date:  2011-10-28

6.  Tuberculous uveitis.

Authors:  Ahmed M; Abu El-Asrar; Marwan Abouammoh; Hani S Al-Mezaine
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

Review 7.  Anti-tubercular therapy for intraocular tuberculosis: A systematic review and meta-analysis.

Authors:  Ae Ra Kee; Julio J Gonzalez-Lopez; Aws Al-Hity; Bhaskar Gupta; Cecilia S Lee; Dinesh Visva Gunasekeran; Nirmal Jayabalan; Robert Grant; Onn Min Kon; Vishali Gupta; Mark Westcott; Carlos Pavesio; Rupesh Agrawal
Journal:  Surv Ophthalmol       Date:  2016-03-10       Impact factor: 6.048

8.  Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis.

Authors:  M Ang; W Wong; C C L Ngan; S-P Chee
Journal:  Eye (Lond)       Date:  2012-02-03       Impact factor: 3.775

9.  Ocular Tuberculosis Initially Presenting as Central Retinal Vein Occlusion.

Authors:  Muiz Mahyudin; May May Choo; Norlina Mohd Ramli; Sharifah S Omar
Journal:  Case Rep Ophthalmol       Date:  2010-08-02

10.  Case report: atypical presentation of Mycobacterium tuberculosis uveitis preceding nodular scleritis.

Authors:  Sunee Chansangpetch; Anita Manassakorn; Prasart Laksanaphuk; Usanee Reinprayoon
Journal:  BMC Infect Dis       Date:  2015-10-28       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.